-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dot-plots-methods.pdf
October 01, 2021 - in a clear and concise way, in order to
facilitate judgments of the overall balance of benefits and harms … In addition, dot plots do not need to be
restricted to harms and also could be adapted to summarize … Our tool could be used for outcomes that are benefits as well as harms. … We created a Stata module to produce dot plots from pooled data for multiple outcomes
(benefits or harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
January 01, 2014 - For patients with chronic venous leg
ulcers, what are the benefits and harms of
using dressings that … For patients with chronic venous
leg ulcers, what are the benefits and
harms of surgical procedures … For patients with chronic venous
leg ulcers, what are the benefits and
harms of surgical procedures … Insufficient
3c What are the relative benefits and harms of different surgical interventions? … …for reporting harms.
1. Listed by category, not according to previous rankings.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - Questions
The objective of this comparative effectiveness review
(CER) is to examine the benefits and harms … All three classes of therapy
are associated with known harms that are clearly defined
within clinical … practice guidelines.4,8,32 Some harms such
as changes in weight or the lipid profile may surface
in … Unfortunately, the longest followup
period among included studies in which harms were
reported was … A similar opportunity arises with harms,
as even in the current literature base harms were rarely
evaluated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
January 01, 2017 - For studies specifically on harms of antipsychotic drugs, populations can be mixed-diagnoses, as the … harms are not diagnosis-
specific
2. … How do the benefits and harms of psychosocial and
other nonpharmacological treatments for adults with … Harms Outcomes
Overall rates of patients reporting adverse events were 11
to 20 percent higher with … Harms Outcomes
Four trials and seven systematic reviews assessed or
reported any type of harms associated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
December 01, 2015 - Key Question 3: What are the harms of diagnostic tests
per se, and what are the treatment-related harms … For Key Question 3, we considered adverse
effects, including direct harms of testing and harms of
test-directed … Key Question 3: What are the harms of
diagnostic tests per se, and what are the
treatment-related … The fact that so
few studies reported harms raises concerns about selective
outcome reporting. … Adverse Events of Testing
Information on harms was often incomplete and poorly
reported.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
April 01, 2012 - We analyzed harms regardless of how
authors perceived the causality of treatments. … The methods to assess harms were not assessed
for validity. … Weight loss and exercise improved UI in
obese women without evident harms. … Which factors are associated with
differences in harms remains unclear. … Benefits and harms with drugs did not differ
by individual quality criteria.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0107_05-19-2009.pdf
January 01, 2009 - Potential harms will also be important to address.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
January 30, 2014 - We added a separate Key Question for harms and
adverse effects associated with interventions. … Harms will be collected
from the studies included for effectiveness, plus cohort studies if only RCTs … The review will
identify and analyze the evidence for harms of pharmacologic interventions used to … We will extract harms data reported in the grey literature,
including integrated safety reports from … Potential adverse effects / harms of pharmacologic interventions include:
• Metabolic effects: weight
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
May 14, 2010 - sustaining a fracture
during the follow-up period) (c)
KQ4: What are the short- and long-term harms … (when used specifically to treat or prevent low bone density/osteoporotic fracture), and
do these harms … • Outcomes:
- Any reported harms/adverse events (AEs) that can be directly associated with use … - Studies that report harms but that do not report fracture risk as an outcome will
also be considered … Assessing harms when comparing medical
interventions.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
February 01, 2018 - Systematic Reviews Methods Guide
www.ahrq.gov
Presenter
Presentation Notes
Prioritization and Selection of Harms … for Inclusion in Systematic Reviews
This presentation entitled: Prioritization and Selection of Harms … Prioritization and Selection of Harms for Inclusion in Systematic Reviews.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
February 01, 2018 - Systematic Reviews Methods Guide
www.ahrq.gov
Presenter
Presentation Notes
Prioritization and Selection of Harms … for Inclusion in Systematic Reviews
This presentation entitled: Prioritization and Selection of Harms … Prioritization and Selection of Harms for Inclusion in Systematic Reviews.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
November 29, 2016 - naloxone in the out-of-hospital setting from EMS personnel, what are the
comparative benefits and harms … do not
improve after an initial dose of intranasal naloxone), what are the effects on benefits and
harms … are alert and
oriented after naloxone administration by EMS personnel, what are the benefits and
harms … hospital admission, cost to the EMS agency for providing treatment);
and adverse effects and other harms … for providing
treatment
Naloxone
Administration**
KQs 1, 2***
No transfer to
hospital
Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - The Key Questions
Key Question 1a: What are the benefits and harms of pharmacologic treatment options … Key Question 1b: What are the benefits and harms of non-pharmacologic treatment options
(foot care, … Key Question 2a: What are the benefits and harms of pharmacologic treatment options to
improve the symptoms … Key Question 2b: What are the benefits and harms of non-pharmacologic treatment options
(alpha-lipoic … • Harms (KQ2a and KQ2b):
Adverse effects reported in >10% of patients and all dropouts [10% is generally
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_prepublication-draft_20120523.pdf
August 10, 2017 - Key Questions
Open for comment until Aug. 10, 2017
Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/methods-guide_prepublication-draft_03-2011.pdf
January 01, 2011 - Key Questions
Open for comment until Aug. 10, 2017
Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/mrsascreening_protocol_20110602.pdf
August 10, 2017 - Key Questions
Open for comment until Aug. 10, 2017
Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0288_03-10-2008.pdf
January 01, 2008 - Despite the evidence for
harms, clinicians may still be prescribing and using the terbutaline pump and
-
effectivehealthcare.ahrq.gov/sites/default/files/20090427identtifyingtopics.pdf
August 10, 2017 - Key Questions
Open for comment until Aug. 10, 2017
Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/decision-models-guidance-160915.pdf
August 10, 2017 - Key Questions
Open for comment until Aug. 10, 2017
Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/module-i-ahrqs-vision-for-theory-and-principles-of-stakeholder-engagement.pdf
August 10, 2017 - Key Questions
Open for comment until Aug. 10, 2017
Harms